Desq Long
Sign in

Company

Rapport Therapeutics, Inc.

RAPP · CIK 0002012593

SEC FORM 4
$64,447.58

Rapport Therapeutics, Inc. (RAPP)

Sale of 2,210 shares at $29.1618 per share.

Reporting Person Ceesay Abraham · Officer Title Chief Executive Officer · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001193125-26-430504 · filed 2026-10-23 · View filing →

SEC FORM 4CLUSTER · 6 INSIDERS
$1,664,824.35

Rapport Therapeutics, Inc. (RAPP)

Purchase of 61,694 shares across 6 reporting persons.

Transaction Code P · Reporting Persons 6

  • Ignelzi Troy A., Chief Financial OfficerPurchase of 5,500 shares at $26.10 per share.$143,550.00
  • MARAGANORE JOHNPurchase of 8,239 shares at $26.3799 per share.$217,344.00
  • MARAGANORE JOHNPurchase of 1,172 shares at $26.9173 per share.$31,547.08
  • PAUL STEVEN MPurchase of 35,714 shares at $27.28 per share.$974,277.92
  • Young Wendy B.Purchase of 3,789 shares at $26.39 per share.$99,991.71
  • Silva Paul MPurchase of 3,680 shares at $27.075 per share.$99,636.00
  • Sanchez RamiroPurchase of 3,600 shares at $27.3549 per share.$98,477.64

Surfaced by rule: 6 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.

Traded Oct 21, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001193125-26-428018 · filed 2026-10-21 · View filing →

Source: SEC Form 4 · 0001193125-26-429071 · filed 2026-10-22 · View filing →

Source: SEC Form 4 · 0001193125-26-429073 · filed 2026-10-22 · View filing →

Source: SEC Form 4 · 0001193125-26-429074 · filed 2026-10-22 · View filing →

Source: SEC Form 4 · 0001193125-26-429075 · filed 2026-10-22 · View filing →

Source: SEC Form 4 · 0001193125-26-430397 · filed 2026-10-23 · View filing →

SEC FORM 4
$35,167.02

Rapport Therapeutics, Inc. (RAPP)

Sale of 1,147 shares at $30.6600 per share.

Reporting Person Ceesay Abraham · Officer Title Chief Executive Officer · Transaction Code S

Traded Oct 7, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001193125-26-417919 · filed 2026-10-08 · View filing →

SEC FORM 4
$108,105.97

Rapport Therapeutics, Inc. (RAPP)

Sale of 3,375 shares at $32.0314 per share.

Reporting Person Ceesay Abraham · Officer Title Chief Executive Officer · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001193125-26-417919 · filed 2026-10-08 · View filing →

SEC FORM 4
$261,813.47

Rapport Therapeutics, Inc. (RAPP)

Sale of 7,925 shares at $33.0364 per share.

Reporting Person Gault Cheryl · Officer Title Chief Operating Officer · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001193125-26-410734 · filed 2026-10-01 · View filing →

SEC FORM 4
$70,042.87

Rapport Therapeutics, Inc. (RAPP)

Sale of 2,075 shares at $33.7556 per share.

Reporting Person Gault Cheryl · Officer Title Chief Operating Officer · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001193125-26-410734 · filed 2026-10-01 · View filing →

SEC FORM 4
$76,230.09

Rapport Therapeutics, Inc. (RAPP)

Sale of 1,952 shares at $39.0523 per share.

Reporting Person Ceesay Abraham · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001193125-26-401017 · filed 2026-09-24 · View filing →

SEC FORM 4
$8,569.94

Rapport Therapeutics, Inc. (RAPP)

Sale of 215 shares at $39.8602 per share.

Reporting Person Ceesay Abraham · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001193125-26-401017 · filed 2026-09-24 · View filing →

SEC FORM 4
$1,765.15

Rapport Therapeutics, Inc. (RAPP)

Sale of 43 shares at $41.05 per share.

Reporting Person Ceesay Abraham · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001193125-26-401017 · filed 2026-09-24 · View filing →

SEC FORM 4
$325,308.26

Rapport Therapeutics, Inc. (RAPP)

Sale of 7,141 shares at $45.5550 per share.

Reporting Person Ceesay Abraham · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386436 · filed 2026-09-09 · View filing →

SEC FORM 4
$49,189.71

Rapport Therapeutics, Inc. (RAPP)

Sale of 1,069 shares at $46.0147 per share.

Reporting Person Ceesay Abraham · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386436 · filed 2026-09-09 · View filing →

SEC FORM 4
$1,046,420.57

Rapport Therapeutics, Inc. (RAPP)

Sale of 20,799 shares at $50.3111 per share.

Reporting Person Yeleswaram Krishnaswamy · Officer Title Chief Development Officer · Transaction Code S

Traded Aug 25, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001193125-26-368244 · filed 2026-08-26 · View filing →

SEC FORM 4
$827,184.18

Rapport Therapeutics, Inc. (RAPP)

Sale of 16,201 shares at $51.0576 per share.

Reporting Person Yeleswaram Krishnaswamy · Officer Title Chief Development Officer · Transaction Code S

Traded Aug 25, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001193125-26-368244 · filed 2026-08-26 · View filing →

SEC FORM 4
$937,957.49

Rapport Therapeutics, Inc. (RAPP)

Sale of 18,921 shares at $49.5723 per share.

Reporting Person Ceesay Abraham · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 25, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001193125-26-368285 · filed 2026-08-26 · View filing →

SEC FORM 4
$657,977.63

Rapport Therapeutics, Inc. (RAPP)

Sale of 13,160 shares at $49.9983 per share.

Reporting Person Yeleswaram Krishnaswamy · Officer Title Chief Development Officer · Transaction Code S

Traded Aug 24, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001193125-26-368244 · filed 2026-08-26 · View filing →

SEC FORM 4
$20,159.60

Rapport Therapeutics, Inc. (RAPP)

Sale of 404 shares at $49.90 per share.

Reporting Person Yeleswaram Krishnaswamy · Officer Title Chief Development Officer · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001193125-26-359189 · filed 2026-08-20 · View filing →

SEC FORM 4
$171,837.20

Rapport Therapeutics, Inc. (RAPP)

Sale of 3,664 shares at $46.8988 per share.

Reporting Person Ceesay Abraham · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001193125-26-346995 · filed 2026-08-12 · View filing →

SEC FORM 4
$936,846.30

Rapport Therapeutics, Inc. (RAPP)

Sale of 19,500 shares at $48.0434 per share.

Reporting Person Ceesay Abraham · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001193125-26-346995 · filed 2026-08-12 · View filing →

SEC FORM 4
$281,721.08

Rapport Therapeutics, Inc. (RAPP)

Sale of 5,794 shares at $48.6229 per share.

Reporting Person Ceesay Abraham · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001193125-26-346995 · filed 2026-08-12 · View filing →

SEC FORM 4
$651,491.89

Rapport Therapeutics, Inc. (RAPP)

Sale of 14,171 shares at $45.9736 per share.

Reporting Person Ceesay Abraham · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001193125-26-346995 · filed 2026-08-12 · View filing →

SEC FORM 4
$391,279.92

Rapport Therapeutics, Inc. (RAPP)

Sale of 8,370 shares at $46.7479 per share.

Reporting Person Ceesay Abraham · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001193125-26-346995 · filed 2026-08-12 · View filing →